Palvella Therapeutics (PVLA) FCF Margin Growth (1y) (2015 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -150,879.00 |
| Sep 30, 2023 | 334,537.00 |
| Jun 30, 2023 | 37,393.00 |
| Mar 31, 2023 | -36,167.00 |
| Sep 30, 2022 | -289,732.00 |
| Jun 30, 2022 | -160,942.00 |
| Mar 31, 2022 | -11,520.00 |
| Dec 31, 2021 | 50,607.00 |
| Sep 30, 2021 | -28,222.00 |
| Jun 30, 2021 | 126,477.00 |
| Mar 31, 2021 | 3,505.00 |
| Dec 31, 2020 | -24,986.00 |
| Sep 30, 2020 | -14,385.00 |
| Jun 30, 2020 | 12,241.00 |
| Mar 31, 2020 | 4,959.00 |
| Dec 31, 2019 | 110,809.00 |
| Sep 30, 2019 | 9,082.00 |
| Jun 30, 2019 | -13,854.00 |
| Mar 31, 2019 | -92,304.00 |
| Dec 31, 2018 | -157,346.00 |
| Sep 30, 2018 | -106,494.00 |
| Jun 30, 2018 | 30,750.00 |
| Mar 31, 2018 | -116,076.00 |
| Dec 31, 2017 | 22,514.00 |
| Sep 30, 2017 | 136,967.00 |
| Jun 30, 2017 | 18,703.00 |
| Mar 31, 2017 | 174,847.00 |
| Dec 31, 2016 | -92,731.00 |
| Sep 30, 2016 | 41,942.00 |
| Jun 30, 2016 | 137,038.00 |
| Mar 31, 2016 | 182,687.00 |
| Sep 30, 2015 | -82,578.00 |
| Jun 30, 2015 | -145,651.00 |